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Background. The value of bronchoalveolar lavage (BAL) still remains controversial, prompting a need for further 
improvement. The purpose of this study was to develop and evaluate a sequential analysis of cell content in fractional 
BAL (FBAL) from the airways and alveolar sacs with incorporation of the cellular morphologic features. Methods. 
Initially, 30 ml saline was infused into a subsegmental lobe of the lung and the recovered fluid was assigned as FBAL-I 
being mainly originated from whole airways. The second and third lavages (FBAL-II and FBAL-III) each were per-
formed using 50 ml saline being from more distal portions of airways and alveolar sacs respectively in the same lobe. 
Total cell number/ml and percentages of macrophages, lymphocytes, neutrophils, and eosinophils in each fraction 
together with their morphological alterations and mast cells, basophils and Masson bodies were assessed. Results. 
In the 12 controls, percentage of neutrophils was high and lymphocytes and macrophages were low in FBAL-I while 
in FBAL-III, neutrophils decreased to nearly nil and lymphocytes and macrophages were increased. Analysis of FBAL 
from 76 patients with sarcoidosis and 14 with hypersensitivity pneumonitis (HP) revealed that a predominance of 
small, round and well-differentiated lymphocytes with relative absence of neutrophils, basophils and Masson bodies 
correlated best with sarcoidosis. In contrast, neutrophil predominance and presence of lymphocytes having deep 
nuclear indentations and abundant cytoplasm with a process resembling a “hand-mirror” correlated well with HP. 
Conclusions. Evaluation of FBAL together with cellular morphological features especially characteristics of lym-
phocytes provides valuable information for establishing the diagnosis in interstitial lung diseases. 
Key words: Bronchoalveolar lavage procedure; interstitial lung diseases; sarcoidosis; hypersensitivity pneumonia; lympho-
cyte morphology; neutrophil; Masson bodies. 
Introduction 
Bronchoalveolar lavage (BAL) has been widely 
applied as a routine tool in laboratories of respiratory 
disease 1. The BAL technique is safe and minimally 
invasive, and the presence of cell patterns can sup-
port clinical diagnosis in the absence of biopsy or 
when the clinical feature is compatible 2, 3. However, 
the application of BAL still remains controversial as 
the results obtained so far were based on a variety of 
techniques or methods thus introducing considerable 
variations in the implications 4. Although it is well 
recognized that correlations between BAL fluid cells 
and corresponding tissue cell extractions are better 
for lymphocyte infiltration in granulomatous lung 
disease  5, morphological features of lymphocytes 
have not been well defined and incorporated in rela-
tion to the pathological conditions.   Int. J. Med. Sci. 2009, 6 
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The primary objective of this study was to de-
velop a sequential analysis of cells in FBAL with spe-
cial references to the distribution of inflammatory 
cells in the airways and alveolar sacs combined with 
morphological alteration of lymphocytes in relation 
to the functional states; migration of mast cells and 
basophils. Using this method, lymphocyte morphol-
ogy in hypersensitivity pneumonitis (HP) was 
sharply contrasted with the other lymphocyte-rich 
diseases such as sarcoidosis.   
Materials and Methods 
Fractional analysis of cells in BAL fluid. After pre-
medication with atropine and hydroxyzine, a bron-
choscope was inserted under local anesthesia with 
lidocaine and wedged at orifice of the objective 
sub-segment of a lobe. The first lavage was done with 
a 30ml of sterile 0.9% saline (FBAL-I) which was as-
signed as “whole airway” lavage. Subsequently, the 
second (FBAL-II) and third (FBAL-III) lavages were 
performed each with a 50 ml saline and were consid-
ered to be from “distal airway” and “alveolar sac” 
respectively (Figure 1). The percent recovery rate of 
lavage fluid and a total cell number were estimated in 
each FBAL, and then cytocentrifuging was done for 5 
minutes at 1,500 rpm at room temperature (Model 
Cytospin 3, Shandon Southern Products Ltd., UK) for 
microscopic evaluation. The cells were stained by 
May-Grunwald Giemsa and Papanicolaou methods. 
The differential cell counts were performed under a 
l i g h t  m i c r o s c o p e  b y  c o u n t i n g  m o r e  t h a n  3 0 0  c e l l s .  
Mast cells and basophils in FBAL were counted and 
graded as 0, 1+ (1/103 cells), 2+ (2 ~5/103 cells) and 
3+ (> 5/103  cells). We further checked non-cellular 
components, including tiny organized proteinous 
accumulations or Masson bodies, foreign bodies, ag-
gregates.  
 
 
Figure 1. Fractional analysis of bronchoalveolar lavage (FBAL) procedure. PCR: polymerase chain reaction. 
 
Control individuals and patients with lung diseases. 
Control individuals were comprised 8 males (mean 
age ±SD: 45.0±13.0), and 4 females (44.8±17.7). We 
reviewed clinicopathological records of a total of 2260 
patients with various lung diseases between 1984 and 
2006 at our Nippon Medical School affiliated hospi-
tals (Table 1). Among them, 76 of sarcoidosis and 14 
of HP patients had both a definite diagnosis with 
histopathological confirmation and all three FBAL 
samples available and therefore selected for detailed 
studies. Written informed consent was obtained from 
each patient when they underwent the examinations. 
This study was also approved by the Ethical Com-
mittee of the Nippon Medical School. 
Clinical features of patients with sarcoidosis. The 76 
patients, including 39 men (35.8±14.5) and 37 women 
(51.8±13.5), were proved by lung biopsy to have de-
veloped characteristic non-caseating epithelioid 
granuloma. Based on chest radiographs, the patients 
were divided into four stages according to the criteria 
established by the American Thoracic Society, Euro-
pean Respiratory Society and WASOG 6. Seven pa-
tients (9.2%) met stage 0, 39 patients (51.3%) stage I, 
14 patients (18.4%) stage II, and 16 patients (21.1%) Int. J. Med. Sci. 2009, 6 
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stage III. Thirty-seven patients (48.7%) showed mul-
tiple organ involvements of sarcoidosis including 
skin, eyes and/or heart. As to smoking habits, 31 
(40.8%) were current smokers, 37 patients (48.7%) had 
never smoked or were past smokers.   
Table 1. Clinical Diagnoses
 (Nippon Medical 
School-affiliated hospitals, April 1984 - February 2006). 
Clinical diagnoses  Patients (％) 
Interstitial lung diseases  734 (32.5) 
  IPF/UIP  101 (4.5) 
  NSIP  33 (1.5) 
  COP/BOOP  109 (4.8) 
  CVD-IP  145 (6.4) 
  The others with IP  346 (15.3) 
Sarcoidosis 265  (11.7) 
Radiographic abnormal shadows  136 (6.0) 
Eosinophilic pneumonia  119 (5.3) 
Leukemia, lymphoma and others  104 (4.6) 
Hypersinsitivity pneumonitis  104 (4.6) 
Pneumoconiosis (Asbestosis, Coal workers)  95 (4.2) 
Malignant tumor (Primary or metastat. Cancer)  81 (3.4) 
Tuberculosis 73  (3.2) 
ARDS/AIP 64  (2.8) 
Fungus, P.Carinii  42 (1.9) 
Bloody sputum  30 (1.3) 
Langerhans cell histiocytosis  19 (0.8) 
Alveolar proteinosis  12 (0.5) 
Mycobacterium infection  11 (0.5) 
Wegener’s granulomatosis  4 (0.2) 
The others  367 (16.2) 
Total 2260 
IPF: idiopathic pulmonary fibrosis 
UIP: usual interstitial pneumonia 
NSIP: non-specific interstitial pneumonia 
COP: cryptogenic organizing pneumonia 
BOOP: bronchiolitis obliterans organizing pneumonia 
CVD-IP: collagen vascular disease-related interstitial pneumonia 
ARDS: acute respiratory distress syndrome 
AIP: acute interstitial pnemonia 
 
 
Clinical features of hypersensitivity pneumonitis. 
The 14 patients, including 6 men (65.3±7.1) and 8 
women (59.0±9.4), were proved by lung biopsy to 
have developed HP. Six patients were non-smokers, 
and 8 current smokers. Four patients were diagnosed 
as having summer type hypersensitivity pneumoni-
tis7, 4 patients had hypersensitivity to chemical mate-
rial, 1 to feathers of bedding, and 5 to unknown 
house dust antigens. In these 5 patients, typical 
symptoms were provoked, and besides, laboratory 
data were compatible when they returned home or to 
work place after cessation of symptoms during brief 
hospitalization. Biopsied lung tissues were compati-
ble with HP, including diffuse infiltration of lym-
phocytes, intra-alveolar corporation of collagenous 
exudate (Masson body) and tiny non-caseating epi-
thelioid granuloma formation.   
Statistical Analysis. Paired-sample t-test was used 
to determine whether there was a statistically signifi-
cant difference between each cell differentials of pa-
tients with sarcoidosis or HP (SPSS Software, SPSS 
Japan Inc.). We focused on the relationship between 
the fractions, including FBAL-I, FBAL-III and 
FBAL-total, radiographic staging and smoking his-
tory. A p-value < 0.05 was considered statistically sig-
nificant. 
Results 
Cell differential rates in control individuals. Among 
control group, neutrophil percentage was highest in 
FBAL-I and decreased to nearly nil in FBAL-III 
(p<0.05). In contrast, lymphocytes and macrophages 
were slightly increased in FBAL-III. The differential 
cell rates in each FBAL did not show any significant 
differences related to the smoking habit (Table 2). 
Table 2. Cell differential ratios in control individuals 
(n=12) and when subdivided into smokers and 
non-smokers. 
Control individuals (n=12)       
   Cell  number 
(x105/mL) 
Mφ(%) Ly(%)  Neu(%) Eo(%) 
FBAL-I 1.08±0.45  88.5±3.0  5.8±1.2  4.7±1.9∗ 1.0±0.45 
FBAL-II  1.83±0.63  90.5±1.1 7.5±0.99 1.5±0.50  0.33±0.21
FBAL-III 2.52±0.76  91.7±1.2 7.3±0.84 0.33±0.21 0.33±0.21
FBAL-total  1.84±0.47  91.0±1.2 7.0±0.73 1.3±0.33∗ 0.50±0.22
Control smokers (n=6)       
   Cell  number 
(x105/mL) 
Mφ(%) Ly(%)  Neu(%) Eo(%) 
FBAL-I  1.4±1.07  85.0±4.6 7.7±0.88 6.0±3.5  1.3±0.67 
FBAL-II 3.01±1.39  89.0±1.2  8.3±1.9  2.3±0.67  0.33±0.33
FBAL-III 3.08±1.04  90.3±1.2 8.7±0.67 0.67±0.33 0.33±0.33
FBAL-total  2.45±0.78  89.7±1.2 8.0±0.58 1.7±0.33  0.67±0.33
Control nonsmkers (n=6)      
   Cell  number 
(x105/mL) 
Mφ(%) Ly(%)  Neu(%) Eo(%) 
FBAL-I 0.87±0.35  92.0±3.2  4.0±1.5  3.3±1.9  0.67±0.67
FBAL-II  1.04±0.33  92.0±1.5 6.7±0.88 0.67±0.33 0.33±0.33
FBAL-III 1.96±1.18  93.0±2.1 6.0±1.2  0.0±0.0 0.33±0.33
FBAL-total 1.22±0.47  92.3±2.0  6.0±1.2  1.0±0.58  0.33±0.33
* p<0.05 as compared with % neutrophils in FBAL-III. 
Mφ: macrophages, Ly: lymphocytes, Neu: neutrophils, Eo: eosi-
nophils 
 
Patients’ group showing the highest rate of lympho-
cytes. Of the 2260 patients, 488 (21.6%) showed a 
lymphocyte rate of higher than 40%. Clinical diagno-
ses of these patients included sarcoidosis (22.1%), IIP 
(14.5%), HP (11.5%), leukemia/lymphoma including 
tumor cells (10.9%), COP/BOOP (9.0%) and others 
(Table 3). Sarcoidosis and HP are the most distin-
guished group of diseases with lymphocyte-related Int. J. Med. Sci. 2009, 6 
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etiology and the diagnosis of these granulomatous 
diseases were well defined by lung biopsy. 
Table 3. Patients’ group showing a highest ratio of lym-
phocyte in FBAL-total 
Clinical Diagnosis  Patients (%) 
Sarcoidosis 108  (22.1) 
IIPs 72  (14.5) 
Hypersensitivity Pneumonitis  38 (11.5) 
Leukemia/Lymphoma 53  (10.9) 
COP/BOOP 44  (9.0) 
Tuberculosis 18  (3.7) 
Lung cancer  10 (2.0) 
Others 145  (29.7) 
Lymphocytes >40% in FBAL-total  488 
IIPs: idiopathic interstitial pneumonias 
COP: cryptogenic organizing pneumonia 
BOOP: bronchiolitis obliterans organizing pneumoni 
 
 
Differential cell rates in sarcoidosis. The mean cell 
numbers in 76 sarcoidosis patients were 1.64±0.30 
x105/mL in FBAL-I, 3.26±0.38 x105/mL in FBAL-III, 
and 2.96±0.36 x105/mL in FBAL-total (1.6-fold in-
crease vs. control). The higher percentages of lym-
phocytes in each fraction were 40.8±2.2% (3.9–82.8%) 
in FBAL-total, 28.5±2.2% in FBAL-I, and 43.9±2.3% in 
FBAL-III respectively (Figure 2). The mean lympho-
cyte percentage of patients who had lung involve-
ment (stage II or III) did not differ in clinical symp-
toms and laboratory data from those of patients with 
no lung involvement (stage 0 or I) (40.3±3.7% vs. 
41.2±2.7%). There were 40 patients, including 18 
smokers, who showed no neutrophil recovery in any 
fractions. Among sarcoidosis smoker patients (n=31), 
mean neutrophil rate was 4.6±2.1 % in FBAL-I com-
pared to 0.8±0.2 % in FBAL-III (p=0.06). On the other 
hand, among sarcoidosis nonsmokers (n=37), mean 
neutrophil rate was 9.7±3.4 % in FBAL-I compared to 
3.2±1.2 % in FBAL-III (p<0.05).  
Differential cell rates in hypersensitivity pneumoni-
tis. The average total cell number was 1.59±0.33 
x105/mL in FBAL-I, 6.45±0.92 x105/mL in FBAL-III, 
and 5.29±0.70 x105/mL in FBAL-total showing a 
2.9-fold increase versus normal control (p<0.05) and 
1.8-fold higher than sarcoidosis (p<0.05). A signifi-
cantly higher proportion of lymphocytes was seen 
(mean 65.2±4.1% ranging from 35.9 to 84.3%) and the 
difference of lymphocyte rates between FBAL-I 
(47.5±5.0%) and FBAL-III (68.9±4.5%) was statistically 
significant. Neutrophil rate in FBAL-I was 17.4±3.4% 
in contrast to 2.9±0.7% in FBAL-III (p<0.05) and 
4.4±0.9% in FBAL-total among HP patients, which 
was significantly higher than in the normal control 
(1.3±0.33%;  P<0.05)  (Figure 3). Lymphocyte rate in 
FBAL-total in HP smoking patients tended to be 
lower than non-smoking patients (60.6±4.9% vs. 
68.1±9.7%), and neutrophil rate in FBAL-total showed 
a higher level in nonsmokers than in smokers 
(5.5±1.9% vs. 3.6±1.2%; no statistical significance).   
 
 
 
 
 
 
 
 
 
Figure 2. Cell differentials in sarcoidosis (n=76). BAL fluid 
cells in sarcoidosis patients were characterized by a higher 
percentage of lymphocyte at each fraction, showing 
40.8±2.2% (3.9–82.8%) FBAL-total (A), while that in FBAL-I 
(B) was 28.5±2.2% compared to 43.9±2.3% in FBAL-III (C) 
(p<0.05). Mean neutrophil rate was 3.1±0.9% in FBAL-total 
among all patients with sarcoidosis, while mean neutrophil 
rate in FBAL-I was 6.9±1.9% compared to 2.0±0.6% in 
FBAL-III (p<0.05). Asterisk indicates a significant difference 
from FBAL-III (p<0.05). Int. J. Med. Sci. 2009, 6 
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Figure 3. Cell differentials in hypersensitivity pneumonitis 
(n=14). A significantly higher proportion of lymphocyte 
was seen in HP patients (mean 65.2±4.1% ranging from 
35.9 to 84.3%). The difference of lymphocyte rates be-
tween FBAL-I (A; 47.5±5.0%) and FBAL-III (C; 68.9±4.5%) 
was statistically significant (p<0.05). Neutrophil rate in 
FBAL-I was 17.4±3.4% in contrast to 2.9±0.7% in FBAL-III 
(p<0.05) and 4.4±0.9% in FBAL-total (A) among HP pa-
tients, which was significantly higher than in the normal 
control (1.3±0.33%) (P<0.05). Asterisk indicates a signifi-
cant difference from FBAL-III (p<0.05). 
 
Comparison of lymphocyte morphology between sar-
coidosis and HP. Sarcoid-lymphocytes were generally 
small in size and appeared mature and well differen-
tiated in morphology (Figure 4). They had a round 
nucleus and the cytoplasm was fairly thin. In con-
trast, HP lymphocytes had fairly abundant cytoplasm 
and occasionally developed an elongated cytoplasmic 
process resembling a hand-mirror in shape. A num-
ber of lymphocytes looked like plasma cell, having 
large basophilic cytoplasm and nucleus with 
wheel-like appearance. In others, the nuclear mem-
brane was highly convoluted like cerebelli-form or 
clover-shape. Nucleus often contained a large nu-
cleolus. Sarcoidosis patients consistently showed a 
different morphology compared with HP patients. 
Other inflammatory cells, particularly eosinophils 
and mast cells were also frequently seen in BALF of 
HP patients (Figure 5). 
 
 
Figure 4. Morphology of sarcoid lymphocytes. The sar-
coid lymphocytes displayed mature, small shape dominant, 
and also regular size cells. They had round-shape nuclei 
and scanty cytoplasm. (Giemsa stain x original magnifica-
tion x 200). 
 
Eosinophils, mast cells and basophils in FBAL. 
Higher eosinophil recovery (>5%) in FBAL-total was 
found in 120 of 546 (22%) of biopsy proven cases. The 
distribution of diseases were as follows; IIP 43 
(35.8%), eosinophilic pneumonia 18 (15.0%), sarcoi-
dosis 6 (5.0%), drug-induced pneumonia 3 (2.5%) and 
others. On the other hand, eosinophil recovery rate 
was highest in the group of eosinophilic pneumonia 
showing 28.2% following by NSIP 6.1%, IPF 5.0% and 
COP/BOOP 4.6%. With May-Grunwald-Giemsa 
staining, mast cells were identifiable by the pur-
ple-red granules in cytoplasm, and were encountered 
in half of a total 546 biopsy cases. Highest level of 
mast cells (3+) were encountered in 96 patients with a 
variety of interstitial lung diseases, including 37 pa-
tients with IIP, 10 sarcoidosis, 7 eosinophilic pneu-
monia, and others. Distribution of mast cells in 7 HP 
patients examined in this study were 3+ (n=3), 2+ 
(n=3) and 1/0 (n=1). Basophilic leukocytes were 
never found in the normal control and most patients. 
Basophils were occasionally found in 13 patients with 
IIP, 3 HP, 5 eosinophilic pneumonia, and others. The 
three HP patients who contained basophils were all at Int. J. Med. Sci. 2009, 6 
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relatively acute stage of HP symptoms and had re-
cently received anti-flu or antibiotics for common 
cold or with tentative diagnosis of bacterial pneumo-
nia. Acute eosinophilic pneumonia also showed ba-
sophil recovery as well as mast cells.   
Masson body in the FBAL from HP patients. For-
mation of intra-alveolar budding or traditionally 
called “Masson body” was found in 8 patients; one 
each with HP, IPF, NSIP, IIPs, dermatomyositis, 
ARDS, organized hemosiderosis and adenocarci-
noma. The existence of such organization lesion is 
considered one of the major histological characteris-
tics including marked lymphocytic infiltration and 
formation of tiny granulation tissues with epithelial 
cell coverage in small airways and alveolar zones. 
M a s s o n  b o d i e s  i n  B A L F  t o rn off from HP alveolar 
walls consisted of the central collagen or fibrin part 
(red color expression by Papanicolaou stain) covered 
with regenerative epithelial cell lining (Figure 6). HP 
macrophages often had a foamy appearance. 
 
 
 
 
Figure 5. Morphology of hypersensitivity pneumonitis (HP) lymphocytes. HP lymphocytes morphology and diameter 
varied considerably. The cell morphology was consistent with activated-type lymphocyte. They presented cytoplasmic 
formations like hand-mirror cells which had cytoplasmic tail (A, arrows), or plasmacytoid cells which had light cytoplasmic 
regions adjacent to nuclei (B, arrow). They also had irregularities in the contours of the nuclear membranes such as 
cerebelli-form (B and C, arrowheads), glove mitt-like or clover-shaped. Other inflammatory cells, particularly eosinophils 
and mast cells (C, arrow) were also frequently seen in BALF of HP patients. (Giemsa stain; original magnification x400). 
 
 
 
 
Figure 6. Masson body in BALF from HP patients. Masson bodies (intraalveolar foci of organizing pneumonia) in BALF are 
torn off from HP alveolar walls, although the frequency is low. Masson bodies (A, arrow) which are synonymous with 
collagen globules, are constructed of the central collagen or fibrin part (red color expression) covered with regenerative 
epithelial cell lining. There are also plenty of foamy macrophages (B, arrow). (Papanicolaou stain; original magnification 
x400). 
 
 
Discussion 
Our study aimed at evaluating a method of 
FBAL for determining cell distribution in airways and 
alveolar sacs separately in conjunction with cellular 
morphological features. In the control individuals, a 
higher neutrophil rate in FBAL-I indicated that con-
stant exposure to outside air might evoke neutrophil 
accumulation on the surface of airway mucosa, which Int. J. Med. Sci. 2009, 6 
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is in accord with the results shown by Yasuoka et al. 
(1985) 8, 9.  
Eosinophils, mast cells and basophils were occa-
sionally found among allergy-related patients in-
cluding HP. The increased infiltration of mast cells 
implies histological feature of organization of colla-
g e n o u s  m a t r i c e s  o r  i n terstitial fibrosis 10. Basophilic 
leukocytes were never found in the normal control 
and most of the patients. The appearance of basophils 
was related to acute exacerbation of allergic disease 
especially in drug-induced pneumonia. Basophils 
have several morphological and functional character-
istics in common with tissue mast cells, such as ex-
pression of the high-affinity IgE receptor which trig-
gers a cascade of intracellular signals that lead to de-
granulation and synthesis of various mediators in-
volved in the development and maintenance of aller-
gic and inflammatory symptoms. Mast cells and ba-
sophils also display a number of growth-factor re-
ceptors and chemokine receptors, besides some of 
which are shared with eosinophils and account for 
the strong, temporal association of their influx into 
tissues 11.  
An intriguing point in our study was the cyto-
logical finding of Masson bodies. We found that 
Masson bodies can be occasionally seen in FBAL from 
H P  a l v e o l a r  w a l l s ,  a s  t h e y  c a n  e a s i l y  d e s q u a m a t e  
from tissue surface into airspace. Masson bodies have 
been described in diffuse alveolar damage and were 
considered as the cytological counterpart of hyaline 
membrane and type II reactive cells 12-14. However, 
the possibilities remain that this material may be the 
cytological counterpart of intra-alveolar loose fibrotic 
buds. The existence of such organized tissue frag-
ments is an excellent hallmark of inflammatory lung 
tissue that triggers their development.   
Among sarcoidosis patients in our study, mean 
neutrophil rate was increased in FBAL-I compared to 
FBAL-III, particularly in nonsmokers. Furthermore 18 
smokers had no neutrophil recovery at any FBAL 
specimen. This result might suggest that neutrophils 
are not a major contributor to facilitate a milieu for 
lung sarcoidosis. Neutrophil infiltration often found 
in smokers’ BAL fluid is rather limited in sarcoidosis, 
although the underlying reason awaits future clarifi-
cation.  
 In summary, we developed and evaluated a 
sequential analysis of cell content in FBAL in patients 
with various interstitial lung diseases. This method 
determines inflammatory cell differentials in the air-
ways and alveolar sacs separately together with as-
sessment of the cellular morphological features. Our 
results showed that neutrophils consistently recov-
ered from the airways surface regardless of smoking 
history. Lymphocytes were quite unusual in mor-
phology, implying a functional activation in HP while 
lymphocyte rate in FBAL did not depend on activity 
of disease in sarcoidosis or HP. In addition, finding of 
encapsulated exudates may suggest desquamation of 
early stage of Masson body which implies possible 
diagnosis in a limited number of diseases. We believe 
that evaluation of FBAL together with cellular mor-
phological features especially the characteristics of 
lymphocytes provides valuable information for es-
tablishing the diagnosis of specific interstitial lung 
disease.  
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